Yalcin I - Search Results

1

Surgical Treatment of Metastatic Ovarian Tumors From Extragenital Primary Sites.

Sal V, Demirkiran F, Topuz S, Kahramanoglu I, Yalcin I, Bese T, Sozen H, Tokgozoglu N, Salihoglu Y, Turan H, Iyibozkurt C, Kolomuc T, Sofiyeva N, Berkman S, Arvas M. Sal V, et al. Among authors: yalcin i. Int J Gynecol Cancer. 2016 May;26(4):688-96. doi: 10.1097/IGC.0000000000000673. Int J Gynecol Cancer. 2016. PMID: 26937750

2

Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.

Yalcin I, Meydanli MM, Turan AT, Taskin S, Sari ME, Gungor T, Akbayir O, Ayhan A. Yalcin I, et al. Int J Clin Oncol. 2018 Apr;23(2):329-337. doi: 10.1007/s10147-017-1215-x. Epub 2017 Nov 16. Int J Clin Oncol. 2018. PMID: 29143144

3

Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?

Sahin H, Sari ME, Cuylan ZF, Haberal AN, Sirvan L, Coban G, Yalcin I, Güngör T, Celik H, Meydanli MM, Ayhan A. Sahin H, et al. Among authors: yalcin i. Arch Gynecol Obstet. 2018 Apr;297(4):1005-1013. doi: 10.1007/s00404-018-4651-6. Epub 2018 Jan 30. Arch Gynecol Obstet. 2018. PMID: 29383437

4

Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?

Sahin H, Meydanli MM, Sari ME, Yalcin I, Çoban G, Ozkan NT, Cuylan ZF, Erdem B, Gungorduk K, Akbayir Ö, Dede M, Salman MC, Güngör T, Ayhan A. Sahin H, et al. Among authors: yalcin i. J Ovarian Res. 2018 Mar 5;11(1):21. doi: 10.1186/s13048-018-0393-0. J Ovarian Res. 2018. PMID: 29506569 Free PMC article.

5

Clinicopathological analysis of borderline ovarian tumours and risk factors related to recurrence: experience of single institution.

Sozen H, Vatansever D, Topuz S, Iyibozkurt C, Kandemir H, Yalçin I, Onder S, Yavuz E, Salihoglu Y. Sozen H, et al. Among authors: yalcin i. J Obstet Gynaecol. 2019 Feb;39(2):253-258. doi: 10.1080/01443615.2018.1499076. Epub 2018 Oct 29. J Obstet Gynaecol. 2019. PMID: 30372646 Free article.

6

Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.

Ayhan A, Şahin H, Sari ME, Yalçin I, Haberal A, Meydanli MM. Ayhan A, et al. Among authors: yalcin i. Int J Gynecol Cancer. 2019 Mar;29(3):505-512. doi: 10.1136/ijgc-2018-000069. Epub 2019 Jan 21. Int J Gynecol Cancer. 2019. PMID: 30665899

7

Is It Possible to Develop a Prediction Model for Lymphovascular Space Invasion in Endometrioid Endometrial Cancer?

Meydanli MM, Aslan K, Öz M, Muftuoglu KH, Yalcin I, Engin-Ustun Y. Meydanli MM, et al. Among authors: yalcin i. Int J Gynecol Pathol. 2020 May;39(3):213-220. doi: 10.1097/PGP.0000000000000596. Int J Gynecol Pathol. 2020. PMID: 31033799

8

SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study.

Kahramanoglu I, Meydanli MM, Taranenka S, Ayhan A, Salman C, Sanci M, Demirkiran F, Ortac F, Haidopoulos D, Sukhin V, Kaidarova D, Stepanyan A, Farazaneh F, Aliyev S, Ulrikh E, Kurdiani D, Yalcin İ, Mavrichev S, Akilli H, Sarı ME, Pletnev A, Aslan K, Bese T, Kairbayev M, Vlachos D, Gultekin M. Kahramanoglu I, et al. Among authors: yalcin i. Int J Gynecol Cancer. 2019 Oct;29(8):1271-1279. doi: 10.1136/ijgc-2019-000643. Epub 2019 Sep 2. Int J Gynecol Cancer. 2019. PMID: 31481453

9

Coexistence of uterine adenomyosis is not associated with a better prognosis in endometrioid-type endometrial cancer.

Aslan K, Sarı ME, Yalçın HR, Yalçın İ, Cüylan ZF, Özdal B. Aslan K, et al. Among authors: yalcin hr, yalcin i. Ir J Med Sci. 2020 Aug;189(3):835-842. doi: 10.1007/s11845-020-02172-z. Epub 2020 Jan 23. Ir J Med Sci. 2020. PMID: 31970616

10

Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).

Altin D, Taskin S, Tokgozoglu N, Vatansever D, Guler AH, Gungor M, Tasci T, Turan H, Kahramanoglu I, Yalcin I, Celik C, Kose F, Ortac F, Arvas M, Ayhan A, Taskiran C. Altin D, et al. Among authors: yalcin i. J Surg Oncol. 2021 Feb;123(2):638-645. doi: 10.1002/jso.26310. Epub 2020 Dec 1. J Surg Oncol. 2021. PMID: 33259650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters